STOCK TITAN

Spruce Biosciences: OrbiMed Advisors reports 5.6% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Spruce Biosciences, Inc. (SPRB) is the issuer in an amended beneficial-ownership report by OrbiMed Advisors LLC, OrbiMed Genesis GP LLC and OrbiMed Capital LLC. As of September 30, 2026, Advisors and Genesis each reported beneficial ownership of 162,000 shares, or 5.6%, with shared voting and dispositive power; Capital reported 80,800 shares, or 2.8%, with sole voting and dispositive power. The reporting persons also stated that they held 8.5% of the common stock on behalf of other persons.

Beneficially owned shares — OrbiMed Advisors LLC 162,000 shares As of September 30, 2026; shared voting and dispositive power
Percentage of class — OrbiMed Advisors LLC 5.6% Beneficial ownership
Beneficially owned shares — OrbiMed Genesis GP LLC 162,000 shares As of September 30, 2026; shared voting and dispositive power
Percentage of class — OrbiMed Genesis GP LLC 5.6% Beneficial ownership
Beneficially owned shares — OrbiMed Capital LLC 80,800 shares As of September 30, 2026; sole voting and dispositive power
Percentage of class — OrbiMed Capital LLC 2.8% Beneficial ownership
Shares held on behalf of other persons 8.5% The reporting persons stated this was their aggregate shareholding on behalf of other persons
beneficially owned regulatory
"Aggregate amount beneficially owned by each reporting person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power regulatory
"Shared voting power: 162,000 shares"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power: 162,000 shares"
sole voting power regulatory
"Sole voting power: 80,800 shares"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power regulatory
"Sole dispositive power: 80,800 shares"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
management committee regulatory
"Investment and voting power through a management committee"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SPRB shares did each OrbiMed reporting person report?

OrbiMed Advisors LLC and OrbiMed Genesis GP LLC each reported 162,000 shares (5.6%); OrbiMed Capital LLC reported 80,800 shares (2.8%).

Who exercises voting and investment power over the reported SPRB shares?

The entities said a management committee comprised of Carl L. Gordon, W. Carter Neild and Geoffrey C. Hsu exercises investment and voting power over the shares. Each committee member disclaimed beneficial ownership of the reported shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





85209E208

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



OrbiMed Advisors LLC
Signature:/s/ Carl L. Gordon
Name/Title:Carl L. Gordon / Member
Date:11/16/2026
OrbiMed Genesis GP LLC
Signature:/s/ Carl L. Gordon
Name/Title:Carl L. Gordon / Member
Date:11/16/2026
OrbiMed Capital LLC
Signature:/s/ Carl L. Gordon
Name/Title:Carl L. Gordon / Member
Date:11/16/2026

Keep reading